Patent delisted for Merck Sharp drug PREVYMIS

Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three…

The post Patent delisted for Merck Sharp drug PREVYMIS appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!